Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006616
Filing Date
2025-03-04
Accepted
2025-03-04 17:27:04
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 form4-03042025_100357.html 4  
1 form4-03042025_100357.xml 4 9276
  Complete submission text file 0001415889-25-006616.txt   10755
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Kunkel Lori Anne (Reporting) CIK: 0001536368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 25706646

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)